Compare INMB & SKYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | INMB | SKYA |
|---|---|---|
| Founded | 2015 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 64.7M | 59.7M |
| IPO Year | 2018 | 2022 |
| Metric | INMB | SKYA |
|---|---|---|
| Price | $1.62 | $2.79 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $7.00 | N/A |
| AVG Volume (30 Days) | 295.4K | ★ 1.8M |
| Earning Date | 11-02-2026 | 11-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 11.85 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $50,000.00 | ★ $204,120.00 |
| Revenue This Year | N/A | $35,369.33 |
| Revenue Next Year | N/A | $9.94 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 257.14 | N/A |
| 52 Week Low | $1.09 | $0.91 |
| 52 Week High | $2.60 | $2.83 |
| Indicator | INMB | SKYA |
|---|---|---|
| Relative Strength Index (RSI) | 27.80 | 75.68 |
| Support Level | $1.36 | $1.60 |
| Resistance Level | $1.76 | N/A |
| Average True Range (ATR) | 0.12 | 0.19 |
| MACD | -0.03 | 0.08 |
| Stochastic Oscillator | 2.92 | 98.37 |
INmune Bio Inc is a clinical stage biotechnology pharmaceutical company focused on developing and commercializing its product candidates to treat diseases where inflammation and immunology cause a dysfunctional immune system contributing to disease. The company's pipeline products include INKmune, XPro1595, and others. It has three product platforms; The CORDStrom product platform, The DN-TNF product platform, and The Natural Killer Cell Priming Platform.
SkyAI Inc is developing financial technology platforms focused on users in emerging markets. Its operations include the use of stablecoin-based payment infrastructure and artificial intelligence (AI) technologies to provide financial access, educational tools, and data analysis services for users in Asia, Latin America, and Africa. The company's platform will utilize the Solana blockchain network to support digital asset and on-chain data applications.